menu
    • menu

    Company profile for Arch Biopartners

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arch Biopartners Inc. is focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch works closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arch BiopartnersCanada Flag
    Country
    Country
    Canada
    Address
    Address
    27 St. Clair Avenue East P.O. Box 305 Toronto, Ontario, M4T 2M5 Canada
    Telephone
    Telephone
    +1 647 428 7031
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://archbiopartners.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arch-biopartners-inc-foiff-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/archbiopartners

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arch Biopartners Closes Non-Brokered Private Placement
    Arch Biopartners Closes Non-Brokered Private Placement

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191449/0/en/Arch-Biopartners-Closes-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Arch Biopartners Arranges Non-Brokered Private Placement
    Arch Biopartners Arranges Non-Brokered Private Placement

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184546/0/en/Arch-Biopartners-Arranges-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Arch Bio Expands Phase 2 AKI Trial To Include Royal Columbian
    Arch Bio Expands Phase 2 AKI Trial To Include Royal Columbian

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181484/0/en/Arch-Biopartners-Expands-Phase-II-Cardiac-Surgery-Associated-AKI-Trial-to-Include-Royal-Columbian-Hospital-in-British-Columbia.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Arch Acquires Breakthrough Platform to Develop New CKD Drugs
    Arch Acquires Breakthrough Platform to Develop New CKD Drugs

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151530/0/en/Arch-Strengthens-its-Position-as-a-Leading-Kidney-Therapeutics-Company-with-the-Acquisition-of-a-Breakthrough-Platform-to-Develop-New-Drugs-Targeting-Chronic-Kidney-Disease-CKD.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    Arch Biopartners Doses 1st Patient in Ph2 LSALT AKI Surgery Trial
    Arch Biopartners Doses 1st Patient in Ph2 LSALT AKI Surgery Trial

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128224/0/en/Arch-Biopartners-Announces-First-Patient-Successfully-Dosed-at-Toronto-General-Hospital-in-Phase-II-Trial-of-LSALT-Peptide-Targeting-Cardiac-Surgery-Associated-Acute-Kidney-Injury.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share
    Arch Biopartners Begins Ph II PONTIAK Trial for Drug-Induced AKI
    Arch Biopartners Begins Ph II PONTIAK Trial for Drug-Induced AKI

    22 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/22/3119331/0/en/Arch-Biopartners-Announces-Start-of-Patient-Recruitment-in-Phase-II-PONTIAK-Trial-Targeting-Drug-Toxin-Related-Acute-Kidney-Injury-AKI.html

    GLOBENEWSWIRE
    22 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search